PIMCO CEO Dr. Mohamed El-Erian Voices Support for Children’s Cancer Hospital Egypt 57357 at ECN Iftar in Los Angeles, CA

Tag Archives: pediatric cancer

Dr. Mohamed A. El-Erian, CEO of PIMCO, a major global investment company, attended the Egypt Cancer Network 57357 (ECN) iftar in Los Angeles along with his wife and daughter. They were inspired by the work that is being done by ECN in support of Children’s Cancer Hospital Egypt 57357 (CCHE). Because of its effectiveness in delivering superior health services to children, they consider the hospital an impressive example of charity innovation and sustainability in Egypt.

Together with his daughter and wife, Dr. El-Erian stated that he was delighted “to support this world-class Egyptian hospital that provides comprehensive cancer care to children at no financial cost to them or their families.”

ECN extends its sincere appreciation to Dr. El-Erian and his family for their visit and for their generosity. The administrations of both ECN and Children’s Cancer Hospital Foundation (CCHF), both recipients of Dr. El-Erian’s humanitarian donation, are grateful that Dr. El-Erian shares their strategic vision to cure children regardless of their ability to pay. ECN and CCHF are equally grateful for Dr. El-Erian’s support of their tireless efforts to make CCHE be a world leader in pediatric cancer care. With Dr. El-Erian’s help, CCHE, by way of ECN and CCHF, is truly on the way to achieving its expansion goal to serve and cure more children in Egypt.

 

Dana-Farber/Children’s Hospital Cancer Center to partner with Egypt Cancer Network and Children’s Cancer Hospital Egypt

Creating Egypt-based fellowship training program for physicians from Egypt, the Middle East and North Africa Region

BOSTON – Dana-Farber/Children’s Hospital Cancer Center is announcing a partnership with the Egypt Cancer Network and Children’s Cancer Hospital Egypt in an effort to improve childhood cancer survival rates and outcomes within Egypt, the Middle East and North Africa. The organizations are collaborating to create an Egypt-based fellowship training program in pediatric oncology for physicians in those regions.

“Since beginning a twinning program between the Dana-Farber/Children’s Hospital Cancer Center and the Children’s Cancer Hospital Egypt in 2006, we have seen significant improvement in the outcome of pediatric cancer patients in Egypt,” said Mark Kieran, MD, PhD, director of medical neuro-oncology at Dana-Farber/Children’s Hospital Cancer Center and member of the medical advisory board for the Children’s Cancer Hospital Egypt 57357’s pediatric oncology fellowship program. “However, there is still a shortage of expertise and resources needed to treat children with cancer in this region.”

“The fellowship is designed to improve the childhood cancer survival rates and outcomes within Egypt, the Middle East and North Africa,” said Kieran. “This collaboration will allow the exchange of information, knowledge and experience for both doctors from the region and from the United States, providing the opportunity for the improvement of treatment and care practices.”

The collaboration will provide a formal fellowship framework for pediatric oncology training and mentoring for Egyptian, African and Middle Eastern pediatricians in line with international standards and will create a pool of qualified pediatric oncologists who can ensure continued progress in improving outcomes for children with cancer in this region.

As part of the fellowship, between 2 and 6 pediatric physicians from the Children’s Cancer Hospital Egypt will travel to Boston to work with specialists at Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC).  In addition, DF/CHCC physicians will rotate at the Children’s Cancer Hospital Egypt to train oncologists there in the latest treatments and care techniques.

About the Dana-Farber / Children’s Hospital Cancer Center

Dana-Farber/Children’s Hospital Cancer Center (DF/CHCC) combines the strengths of Dana-Farber Cancer Institute, a world-class cancer institute, and Boston Children’s Hospital, an internationally known pediatric hospital. For over 60 years, these two Harvard Medical School affiliates have provided comprehensive care for children and adolescents with cancer. Committed to conducting research to better understand and treat childhood cancers, DF/CHCC is the Pediatric Oncology Experimental Therapeutics Investigator Consortium’s (POETIC) only Phase I Clinical Trial site in New England, and is home to one of the world’s most sophisticated and accomplished Pediatric Stem Cell Transplantation centers. DF/CHCC also offers comprehensive transitional and long-term survivorship programs to childhood cancer survivors of all ages.

 

“How CCHE Brought Me Back to Egypt and is Helping to End the Brain-Drain”, by Dr. Hoda M. Amer

Upon my completion of my fellowship in pediatric pathology from Nationwide Children’s Hospital in Columbus, Ohio, I was faced with a serious personal and professional dilemma: was I to return to Egypt, where I was born and raised, or should I remain in the United States, my adoptive home where I had completed many years of medical training?

The decision did not come easily to me. I reflected heavily on my time spent in the United States, not only during my fellowship, but also while completing my residency in anatomic pathology from the University of Medicine and Dentistry in Newark, New Jersey, prior to my fellowship. I also ruminated over my accomplishments in Egypt, including graduating with a degree from the Kasr el Aini Medical School in Cairo.

Part of my dilemma was a lack of knowledge about what kind of opportunities existed for pediatric pathologists in Egypt. I wanted to find a way to put my hard work in the academic and medical realm to practice in a meaningful way. The majority of my friends at home did not hide their pessimism on the subject, and the chances of me returning to Egypt to give back to my country seemed slim.

Suddenly, I had a breakthrough upon hearing the suggestion of my program director, a Syrian-American doctor by the name of Dr. Samir Kahwash. He had attended a conference at particularly unique children’s cancer hospital located in downtown Cairo, Egypt known locally as “57357” or Children’s Cancer Hospital Egypt 57357 (CCHE). He spoke to me very seriously about returning to Egypt and looking into this phenomenal institution as a potential employer. I was soon being given advice by many others who had heard of the hospital and its accomplishments, all of whom believed in the potential of the combination of my academic training and CCHE as an incredible, revolutionary institution.

I am now a proud, full-time member of the CCHE staff, and under the direction of our fantastic pathology department leader, Dr. Hala Taha, we attend to over 3,000 pathology cases per year. We are the only pathology department in Egypt to provide intra-operative consultation for brain tumors and other highly technical, scientific testing procedures.

At CCHE, I was able to bring my two different backgrounds together and solve my personal dilemma. Each contributor, be them staff, advisers, patients, or donors, sustains and builds this hospital day by day. Anyone who has ever suffered the detrimental effects of cancer, either directly or indirectly, can sympathize with the difficulties associated with the disease. When dealing with cancer cases in Egypt, there are many potential additional components to the situation endured by a cancer patient, including extreme poverty and lack of access to cancer treatment and education.

CCHE is also facing a dilemma, as it needs your donations in order to survive and give the youngest of Egypt’s population with cancer a chance at life. CCHE is fully dependent on donations from the Egyptian and the global communities and can only continue to provide free care to pediatric cancer patients with your help.

Please consider donating to the sustenance of CCHE through Egypt Cancer Network (ECN), the organization responsible for raising money for CCHE and supporting cancer initiatives throughout Egypt, at the following link: www.egyptiancancernetwork.org/donate

Also recall that ECN is a 501(c)(3), non-profit organization and that any donation you make will be tax-deductible within the United States.

Your donation is greatly appreciated and will to help fortify the medical infrastructure of this hospital, which in turn helps to bring intellectual capital back to Egypt from abroad, fighting the brain-drain that Egypt has witnessed over the past three decades.

With many thanks,

 

Dr. Hoda M. Amer, Fellow of the College of American Pathologists

 

Patriotic Egyptians, whether at home or abroad, are first attracted to the Children’s Cancer Hospital Egypt (CCHE) 57357 for philanthropic reasons. Once they have had the opportunity to visit the hospital, it becomes clear to this community why CCHE is Egypt’s modern legacy. They consequently become highly committed to supporting this prestigious institution and inspiring model of charity, one which has made a name for itself through its free provision of quality healthcare to children with cancer. While monetary contributions are always welcome, CCHE 57357 is also in need of your research skills and expertise.

As we are about to celebrate our fifth year of operations, the CCHE 57357 development and expansion scheme compels us to fully engage in research centered around pediatric cancer and healthcare sciences.

It is our mission to develop a leading research institute that will carry out basic science research, translational and clinical research in the areas of cancer genetics and biology, epidemiology, treatment, health care policy, healthcare management, pharmacy and nursing. CCHE 57357 already hosts the largest pediatric cancer population and sports the latest hospital informatics system. With the implementation of this research institute, we will then capable of answering research questions with speed and precision, thereby helping to make significant scientific advances not only in the medical field, but also in all other healthcare-related fields, including engineering, IT, and physics, among others. This strategy will aid us in meaningfully contributing to the advancement of public health in Egypt.

In working with CCHE 57357, you have the potential to collaborate closely with international entities, performing studies on the roles that genetic background, environment and lifestyle play in patients’ susceptibility to cancer and the pathogenesis of particular cancers. CCHE 57357 has an impressive repertoire of accomplishments and global connections, having conducted joint research studies with such prestigious institutions as Dana-Farber Cancer Institute, Children’s Hospital Boston and St. Jude’s Children’s Research Hospital. Research collaboration with CCHE 57357 can be conducted from your country of residence or from Egypt, should you decide to take up residence here. In the latter case, you can be assured of CCHE 57357’s full support.

While many are wary of the research standards which prevail in Egypt, there is no doubt that CCHE 57357 has become the icon of change prior to and during this critical time in our nation. This change is one which encompasses the provision of free quality healthcare services to all children with cancer, ushering in a new era in both patient care and the pursuit of scientific discovery and innovation.

The career opportunities available for you at CCHE 57357 are abundant. If you wish to collaborate with some of the most curious minds and passionate individuals, CCHE 57357 awaits you. Working together in our global fight against cancer is an urgent necessity and collaboration is the key to overcoming the hurdles before us. Please contact Dr. Sherif Abouelnaga, CCHE’s Vice-President of Research, Academic Affairs and Outreach, at snaga@57357.com for more information about career opportunities with CCHE 57357.